Current role
Biotechnology · Healthcare
Board Member
2021-05-28–present
Clay B. Siegall, Ph.D.
Board Member
Nurix Therapeutics, Inc. (NRIX)Equibles does not estimate personal net worth.
Get an email with a short summary when Nurix Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NRIX alertsAbout Clay B. Siegall, Ph.D.
Clay B. Siegall, Ph.D. is recorded as Board Member at Nurix Therapeutics, Inc. (NRIX) since May 28, 2021. Nurix Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nurix Therapeutics, Inc. includes Arthur T. Sands (CEO and Board Member), Hans van Houte (CFO), Stefani Wolff (COO) and 7 others.
Affiliation history
-
Current
2021-05-28–present
Company network
Leadership on record at Nurix Therapeutics, Inc.
- Arthur T. Sands CEO, Board Member
- Hans van Houte CFO
- Stefani Wolff COO
- Christine Ring General Counsel
- Anil Kapur Board Member
- Edward C. Saltzman Board Member
- Judith A. Reinsdorf Board Member
- Paul M. Silva Board Member
- Roger Dansey, M.D. Board Member
- Roy D. Baynes, MB.Bch., M.Med., Ph.D. Board Member
Recent activity
No call appearances or filed executive changes recorded yet.